Cardiology research projects
Clinique de Cardiologie Lanaudière actively participates in large-scale national and international clinical research projects. These studies aim to improve the understanding, diagnosis, and treatment of cardiovascular diseases, with a constant focus on innovation and quality of care.
Research experience
Centre d’Investigation Clinique (CIC)
Principal Investigator
Documents to consult :
Recruitment Poster – BalanceD-HF Study Participant Guide – BalanceD-HF Study Information Brochure – BalanceD-HF Study
BalanceD-HF (2025) — Phase III, randomized, double-blind trial evaluating the effect of the combination of balcinrenone and dapagliflozin on heart failure events and cardiovascular mortality in patients with heart failure and renal dysfunction.
COLCOT-T2D (2024) —Randomized trial evaluating the combined effect of colchicine and aspirin on cardiovascular events in patients with type 2 diabetes without a history of cardiovascular disease.
Dal-GenE-2 (2024) — Phase III, randomized, controlled study assessing the efficacy of dalcetrapib in reducing major cardiovascular events in post-acute coronary syndrome patients carrying the AA genotype of the ADCY9 gene.
OCEAN(a) Outcomes (2023) — International, phase III, double-blind trial evaluating the effect of olpasiran, an RNA interference inhibitor, on major cardiovascular events in patients with elevated Lipoprotein(a).